Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|January 16, 2004
A polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseGregg W Stone, Stephen G Ellis, David A Cox, et al.
Breast Cancer Research and Treatment|April 10, 2012
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifeneTrevor J Powles, Susan J Diem, Carol J Fabian, et al.
Circulation|April 14, 2004
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trialGregg W Stone, Stephen G Ellis, David A Cox, et al.
Circulation|November 12, 2003
Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialAmeet Bakhai, Gregg W Stone, Cindy L Grines, et al.
European Heart Journal|June 9, 2007
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The American Journal of Cardiology|October 13, 2004
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas, Eve D Aymong, Roxana Mehran, et al.
American Heart Journal|June 20, 2006
Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trialBruce R Brodie, Gregg W Stone, David A Cox, et al.
The American Journal of Cardiology|July 6, 2013
Implications of myocardial reperfusion on survival in women versus men with acute myocardial infarction undergoing primary coronary interventionStephanie M Meller, Alexandra J Lansky, Ricardo A Costa, et al.
Journal of the American College of Cardiology|April 3, 2010
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialPaul Sorajja, Bernard J Gersh, David A Cox, et al.
Journal of the American College of Cardiology|March 7, 2006
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarctionAmir Halkin, Gregg W Stone, Cindy L Grines, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|January 16, 2004
A polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseGregg W Stone, Stephen G Ellis, David A Cox, et al.
Breast Cancer Research and Treatment|April 10, 2012
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifeneTrevor J Powles, Susan J Diem, Carol J Fabian, et al.
Circulation|April 14, 2004
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trialGregg W Stone, Stephen G Ellis, David A Cox, et al.
Circulation|November 12, 2003
Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialAmeet Bakhai, Gregg W Stone, Cindy L Grines, et al.
European Heart Journal|June 9, 2007
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The American Journal of Cardiology|October 13, 2004
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas, Eve D Aymong, Roxana Mehran, et al.
American Heart Journal|June 20, 2006
Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trialBruce R Brodie, Gregg W Stone, David A Cox, et al.
The American Journal of Cardiology|July 6, 2013
Implications of myocardial reperfusion on survival in women versus men with acute myocardial infarction undergoing primary coronary interventionStephanie M Meller, Alexandra J Lansky, Ricardo A Costa, et al.
Journal of the American College of Cardiology|April 3, 2010
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialPaul Sorajja, Bernard J Gersh, David A Cox, et al.
Journal of the American College of Cardiology|March 7, 2006
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarctionAmir Halkin, Gregg W Stone, Cindy L Grines, et al.
Pageof 17